Neuroplasticity Intervention, Amygdala and Insula Retraining (AIR), Significantly Improves Overall Health and Functioning Across Various Chronic Conditions
- PMID: 38404605
- PMCID: PMC10886399
Neuroplasticity Intervention, Amygdala and Insula Retraining (AIR), Significantly Improves Overall Health and Functioning Across Various Chronic Conditions
Abstract
Chronic conditions, sometimes referred to as functional somatic disorders, such as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), and more recently, long COVID (LC), affect millions of people worldwide. Yet, after decades of research and testing, the etiology and treatment for many of these diseases is still unclear. Recently, a consortium of clinicians and researchers have proposed that while many different chronic conditions exist, the root cause of each may be a similar brain-body connection, as the brain responds to perceived biological threats and transmits danger signals to the body that manifest as somatic symptoms. This hypothesis suggests that treating chronic conditions requires an approach that addresses the neural networks involved. One such method, known as Amygdala and Insula Retraining (AIR), otherwise known as The Gupta Program, has shown promise in recent years for treating such conditions, including ME/CFS, FM, and LC. The present study aimed to demonstrate that AIR could be an effective approach for numerous other chronic illnesses (e.g., Lyme disease, mold illness, mast cell activation syndrome [MCAS]) and others. This novel and exploratory research examined self-reported health and functioning levels before and after using AIR. A series of paired-sample t tests with Bonferroni correction demonstrated that after 3+ months of using AIR (the minimum recommended time for the intervention), participants experienced a significant increase in overall health and functioning for 14 of 16 conditions tested (P < .001 for all but one, which was P = .001) and approached significance for the remaining two conditions (P = .039 and P = .005). Of the 14 signficant findings, 11 had a large effect size and three had a medium effect size. Naturally, this study has limitations. It was a cross-sectional design with a small convenience sample and self-reported data. Future research with larger samples and randomized controlled trials is needed to provide further evidence of AIR's effectiveness. Nonetheless, these preliminary findings suggest that AIR is a viable method for improving the health of people suffering from chronic conditions, and clinicians and researchers might consider incorporating AIR into their protocols for these patients.
Copyright © 2024 InnoVision Professional Media Inc.
Conflict of interest statement
Conflicts of Interest Alexandra J. Bratty is the CEO of AB Research Consulting, which provides consulting services to The Gupta Program, the commercial version of the Amygdala and Insula Retraining (AIR) intervention. Her company was compensated for this work by independent donors.
Similar articles
-
Amygdala and Insula Retraining (AIR) Significantly Reduces Fatigue and Increases Energy in People with Long COVID.Evid Based Complement Alternat Med. 2023 Jul 17;2023:7068326. doi: 10.1155/2023/7068326. eCollection 2023. Evid Based Complement Alternat Med. 2023. PMID: 37492483 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Identification of CD8 T-cell dysfunction associated with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID and treatment with a nebulized antioxidant/anti-pathogen agent in a retrospective case series.Brain Behav Immun Health. 2023 Dec 27;36:100720. doi: 10.1016/j.bbih.2023.100720. eCollection 2024 Mar. Brain Behav Immun Health. 2023. PMID: 38327880 Free PMC article.
-
A scoping review of 'Pacing' for management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): lessons learned for the long COVID pandemic.J Transl Med. 2023 Oct 14;21(1):720. doi: 10.1186/s12967-023-04587-5. J Transl Med. 2023. PMID: 37838675 Free PMC article. Review.
-
The Draft Report by the Institute for Quality and Efficiency in Healthcare Does Not Provide Any Evidence That Graded Exercise Therapy and Cognitive Behavioral Therapy Are Safe and Effective Treatments for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.Diseases. 2023 Jan 16;11(1):11. doi: 10.3390/diseases11010011. Diseases. 2023. PMID: 36648876 Free PMC article. Review.
References
-
- Kozlowska K, Scher S, Helgeland H. Functional somatic symptoms in children and adolescents. A stress-system approach to assessment and treatment. Palgrave Macmillan;. 2020, doi:10.1007/978-3-030-46184-3.
-
- Häuser W, Ablin J, Fitzcharles MA, et al. . Fibromyalgia. Nat Rev Dis Primers. 2015;1(1):15022. doi:10.1038/nrdp.2015.22 - PubMed
-
- Vyas J, Muirhead N, Singh R, Ephgrave R, Finlay AY. Impact of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) on the quality of life of people with ME/CFS and their partners and family members: an online cross-sectional survey. BMJ Open. 2022;12(5):e058128. doi:10.1136/bmjopen-2021-058128 - PMC - PubMed
-
- Solve ME. What are ME/CFS & long COVID? 2022. https://solvecfs.org/
LinkOut - more resources
Full Text Sources